This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

£200 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
4 - 6 June, 2024
Excel London Platinum Suite

Edo Kapetanovic, MD, PhD
CEO at Encelta AG


Edo Kapetanovic, MD PhD is a co-founder and CEO of Encelta. He earned his medical degree from the University of Rijeka, Croatia. He commenced his scientific journey under the mentorship of Prof. Stephanie Helene at Yale University focusing on splicing factor mutations associated with Myelodysplasia (MDS). He proceeded with developing next- generation cell immunotherapies and has completed his PhD in immunoengineering at ETH Zürich under the mentorship of Prof. Sai Reddy. His novel work on universal T-cell technology was selected as the top five innovations for the 2023 ETH Spark Award.

Agenda Sessions

  • Boosting TCE Therapies with Universal T Cells